Clinical Trials Logo
  1. Home
  2. Helicobacter Pylori Eradication
  3. NCT06101420

Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication — P-CABs  

Helicobacter Pylori Eradication Clinical Trial

Official title:
Efficacy of Potassium Competitive Acid Blockers (P-CABs) Versus Proton Pump Inhibitors (PPIs) in the First and the Second Lines Eradication Regimens for H. Pylori in Egyptian Patients

Clinical Trial Summary

This trial assessed the efficacy of potassium competetor acid blocker (P-CAB) in the eradication of H.pylori

Clinical Trial Description

The aim of this study is to compare the effectiveness of Vonaprazan based therapy vs.Proton Pump Inhibitor (PPI)based therapy for the eradication of H.Pylori infection in treatment naive and treatment experienced Egyptian patients.This prospective, non- randomized, controlled study was conducted on symptomatic patients admitted at Tropical Medicine Department at Ain Shams University Hospitals and those presenting at outpatient clinic. The study was conducted in the period from the 1st of January 2022 to the 1st of June 2023. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06101420
Study type Interventional
Source Ain Shams University
Contact
Status Completed
Phase Phase 3
Start date January 1, 2022
Completion date June 1, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT02873065 - Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori Phase 4
Recruiting NCT06349486 - Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication N/A
Completed NCT03924375 - Serum Pepsinogen After H. Pylori Eradication
Recruiting NCT04034641 - Effect of Probiotics on Helicobacter Pylori Eradication Phase 4
Completed NCT04850209 - The Impact of WeChat Group Patient Education on the Eradication Rate of Helicobacter Pylori N/A
Not yet recruiting NCT04558502 - Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication Phase 4
Recruiting NCT06088316 - Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT Phase 4
Recruiting NCT05850117 - Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p N/A
Recruiting NCT05191888 - 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy Phase 4
Recruiting NCT05870397 - Optimal Recheck Time for Helicobacter Pylori Eradication: A Prospective Randomized Trial N/A